USAID [to 9 January 2016]
http://www.usaid.gov/news-information/press-releases

.
January 7, 2016
Prominent Healthcare Companies Partner with USAID to Combat Drug Resistant Tuberculosis
The U.S. Agency for International Development (USAID) announced two new partnerships today to add resources and cutting-edge technologies to fight drug-resistant tuberculosis (TB). Janssen, the pharmaceutical arm of Johnson & Johnson, announced a $15-20 million pledge as part of a new partnership with USAID to combat Multidrug-Resistant Tuberculosis (MDR-TB). USAID will also partner with Cepheid, a maker of molecular systems and tests, to speed diagnosis of MDR-TB through increased access to rapid, accurate diagnostic tools.